The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.
about
The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The novel agent phospho-glycer ...... effect mediated by cyclin D1.
@en
The novel agent phospho-glycerol-ibuprofen-amide
@nl
type
label
The novel agent phospho-glycer ...... effect mediated by cyclin D1.
@en
The novel agent phospho-glycerol-ibuprofen-amide
@nl
prefLabel
The novel agent phospho-glycer ...... effect mediated by cyclin D1.
@en
The novel agent phospho-glycerol-ibuprofen-amide
@nl
P2093
P2860
P356
P1433
P1476
The novel agent phospho-glycer ...... effect mediated by cyclin D1.
@en
P2093
Basil Rigas
Brandon M Vaeth
Despina Komninou
George Mattheolabakis
Gerardo G Mackenzie
Joseph F LaComb
Lauren E Bartels
Ruixue Wang
P2860
P304
P356
10.1093/CARCIN/BGW017
P407
P577
2016-02-10T00:00:00Z